Crucial Update for Long-Term Shareholders of CS Disco Inc. (NYSE: LAW), Five Below, Inc. (NASDAQ: FIVE), Humana Inc. (NYSE: HUM), and Unicycive Therapeutics, Inc. (NASDAQ: UNCY): Grabar Law Office is Looking into Claims for You
Written by Emily J. Thompson, Senior Investment Analyst
Updated: Oct 24 2025
0mins
Should l Buy HUM?
Source: Globenewswire
CS Disco Inc. Securities Fraud Investigation: Grabar Law Office is investigating claims against CS Disco Inc. as a securities fraud class action complaint has survived a motion to dismiss, allowing shareholders who held shares before September 2, 2021, to seek corporate reforms and potential financial returns at no cost.
Five Below, Inc. Class Action Update: A similar investigation is underway for Five Below, Inc., where allegations of misleading financial information have also survived a motion to dismiss, enabling shareholders who held shares before December 1, 2022, to pursue corporate reforms and financial restitution.
Humana Inc. Shareholder Claims: Grabar Law Office is looking into potential breaches of fiduciary duties by Humana Inc. officers, with allegations of misleading statements regarding increased healthcare costs affecting shareholders who purchased shares before July 27, 2022, allowing them to seek reforms and financial returns.
Unicycive Therapeutics, Inc. Investigation: An investigation is being conducted for Unicycive Therapeutics, Inc. regarding false statements about FDA compliance and drug application prospects, with shareholders who held shares before March 29, 2024, eligible to seek corporate reforms and financial restitution.
Trade with 70% Backtested Accuracy
Stop guessing "Should I Buy HUM?" and start using high-conviction signals backed by rigorous historical data.
Sign up today to access powerful investing tools and make smarter, data-driven decisions.
Analyst Views on HUM
Wall Street analysts forecast HUM stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for HUM is 290.39 USD with a low forecast of 231.00 USD and a high forecast of 344.00 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.
19 Analyst Rating
6 Buy
12 Hold
1 Sell
Moderate Buy
Current: 193.550
Low
231.00
Averages
290.39
High
344.00
Current: 193.550
Low
231.00
Averages
290.39
High
344.00
About HUM
Humana Inc. provides Humana insurance services and CenterWell health care services. The Company's segments include Insurance and CenterWell. The Insurance segment consists of Medicare benefits, marketed to individuals or directly via group Medicare accounts, as well as its contract with CMS to administer the Limited Income Newly Eligible Transition (LI-NET) prescription drug plan program and contracts with various states to provide Medicaid, dual eligible demonstration, and Long-Term Support Services benefits. This segment also includes products consisting of employer group commercial fully-insured medical and specialty health insurance benefits marketed to individuals and employer groups. The CenterWell segment includes its pharmacy, primary care, and home solutions operations. The segment also includes its strategic partnerships with WCAS to develop and operate senior-focused, payor-agnostic, primary care centers, as well as its minority ownership interest in hospice operations.
About the author
Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
Overview of Medicare Changes for Retirees in 2026
- Drug Cost Reduction: Thanks to the Inflation Reduction Act, retirees will see significant reductions in prescription drug costs starting in 2026, with price negotiations for the first ten drugs taking effect on January 1, 2026, alleviating financial burdens and improving overall financial health for retirees.
- Rising Medicare Costs: The standard Medicare Part B premium will increase from $185 to $202.90 in 2026, while the annual deductible will rise by $26 to $283, negatively impacting retirees' disposable income, especially as Social Security cost-of-living adjustments may not keep pace with these increases.
- Impact on High-Income Retirees: High-income retirees will face a 9% increase in the income-related monthly adjustment amount (IRMAA) in 2026, with income thresholds rising by about 3%, meaning more retirees will encounter higher healthcare costs, further straining their financial resources.
- Medicare Advantage Market Turmoil: Major insurers like Humana and UnitedHealth have withdrawn Medicare Advantage offerings in hundreds of counties, leading to reduced services and limited networks, with CEOs warning that future payment increases may have a “profoundly negative impact” on seniors' benefits and access to care.
See More
Overview of Medicare Changes for Retirees in 2026
- Lower Drug Costs: Starting in 2026, the CMS can negotiate prices for the first time under the Inflation Reduction Act, potentially lowering costs for retirees on 10 key prescription drugs, particularly those for diabetes and heart conditions, thereby alleviating some financial burdens on retirees.
- Rising Premiums and Deductibles: The standard Medicare Part B premium has increased from $185 to $202.90 in 2026, with the annual deductible rising by $26 to $283, leading 54% of Social Security recipients to feel that the 2.8% COLA is insufficient to offset these increases, which may heighten financial stress for retirees.
- Impact on High-Income Retirees: High-income retirees will face a 9% increase in the income-related monthly adjustment amount (IRMAA) in 2026, with income thresholds rising by about 3%, further straining their healthcare budgets and reducing disposable income.
- Medicare Advantage Chaos: Major insurers like Humana and UnitedHealth have withdrawn Medicare Advantage offerings in hundreds of counties, reducing benefits for additional services; CEOs warn that the proposed 0.9% payment increase for 2027 could have a profoundly negative impact on seniors' benefits and access to care.
See More
U.S. Jobs and Inflation Data Set for Release
- Job Data Expectations: The U.S. is expected to add 60,000 jobs in January, up from 50,000 in December, which could influence the Fed's monetary policy direction amidst ongoing economic uncertainty.
- Inflation Metrics Analysis: The January Consumer Price Index is projected to rise by 0.29% month-over-month and 2.5% year-over-year, showing improvement but still falling short of the Fed's 2% target, potentially affecting investor rate expectations.
- Market Reaction and Risks: Recent signs of labor market weakness, including an ADP report indicating only 22,000 new private sector jobs, may heighten expectations for further Fed rate cuts, although investors remain optimistic about economic resilience.
- Stock Market Rotation Trend: A significant rotation within the stock market is underway, with the Dow Jones Industrial Average rising over 2% this week, reflecting confidence in economic recovery, despite ongoing weakness in tech stocks.
See More
Centene Drops 4.7%, Molina Healthcare Plummets 27%, Humana Declines 1%
- Centene's Financial Performance: Centene's revenue has decreased by 4.7% in the latest reporting period.
- Molina Healthcare's Decline: Molina Healthcare has experienced a significant revenue drop of 27%.
- Humana's Revenue Change: Humana's revenue has seen a slight decline of 1%.
- Overall Industry Trends: The healthcare sector is facing varied financial challenges, with different companies reporting differing levels of revenue change.
See More
US Health Insurer Stocks Decline as Molina Healthcare Projects Annual Profit Below Expectations
Health Insurers' Profit Decline: U.S. health insurers are experiencing a significant drop in profits, falling below annual profit estimates.
Impact of Molina Healthcare: The decline in profits is particularly influenced by Molina Healthcare's performance and forecasts in the health care sector.
See More
Movers in the Market: Amazon, Novo Nordisk, Molina, Roblox, Hub Group, and Others
- Stock Market Movement: Stock futures increased on Friday despite concerns regarding artificial intelligence spending.
- Big Tech Earnings Impact: Recent earnings reports from major technology companies did not alleviate fears related to AI investments.
See More
Overview of Medicare Changes for Retirees in 2026
- Drug Cost Reduction: Thanks to the Inflation Reduction Act, retirees will see significant reductions in prescription drug costs starting in 2026, with price negotiations for the first ten drugs taking effect on January 1, 2026, alleviating financial burdens and improving overall financial health for retirees.
- Rising Medicare Costs: The standard Medicare Part B premium will increase from $185 to $202.90 in 2026, while the annual deductible will rise by $26 to $283, negatively impacting retirees' disposable income, especially as Social Security cost-of-living adjustments may not keep pace with these increases.
- Impact on High-Income Retirees: High-income retirees will face a 9% increase in the income-related monthly adjustment amount (IRMAA) in 2026, with income thresholds rising by about 3%, meaning more retirees will encounter higher healthcare costs, further straining their financial resources.
- Medicare Advantage Market Turmoil: Major insurers like Humana and UnitedHealth have withdrawn Medicare Advantage offerings in hundreds of counties, leading to reduced services and limited networks, with CEOs warning that future payment increases may have a “profoundly negative impact” on seniors' benefits and access to care.
See More
Overview of Medicare Changes for Retirees in 2026
- Lower Drug Costs: Starting in 2026, the CMS can negotiate prices for the first time under the Inflation Reduction Act, potentially lowering costs for retirees on 10 key prescription drugs, particularly those for diabetes and heart conditions, thereby alleviating some financial burdens on retirees.
- Rising Premiums and Deductibles: The standard Medicare Part B premium has increased from $185 to $202.90 in 2026, with the annual deductible rising by $26 to $283, leading 54% of Social Security recipients to feel that the 2.8% COLA is insufficient to offset these increases, which may heighten financial stress for retirees.
- Impact on High-Income Retirees: High-income retirees will face a 9% increase in the income-related monthly adjustment amount (IRMAA) in 2026, with income thresholds rising by about 3%, further straining their healthcare budgets and reducing disposable income.
- Medicare Advantage Chaos: Major insurers like Humana and UnitedHealth have withdrawn Medicare Advantage offerings in hundreds of counties, reducing benefits for additional services; CEOs warn that the proposed 0.9% payment increase for 2027 could have a profoundly negative impact on seniors' benefits and access to care.
See More
U.S. Jobs and Inflation Data Set for Release
- Job Data Expectations: The U.S. is expected to add 60,000 jobs in January, up from 50,000 in December, which could influence the Fed's monetary policy direction amidst ongoing economic uncertainty.
- Inflation Metrics Analysis: The January Consumer Price Index is projected to rise by 0.29% month-over-month and 2.5% year-over-year, showing improvement but still falling short of the Fed's 2% target, potentially affecting investor rate expectations.
- Market Reaction and Risks: Recent signs of labor market weakness, including an ADP report indicating only 22,000 new private sector jobs, may heighten expectations for further Fed rate cuts, although investors remain optimistic about economic resilience.
- Stock Market Rotation Trend: A significant rotation within the stock market is underway, with the Dow Jones Industrial Average rising over 2% this week, reflecting confidence in economic recovery, despite ongoing weakness in tech stocks.
See More
Centene Drops 4.7%, Molina Healthcare Plummets 27%, Humana Declines 1%
- Centene's Financial Performance: Centene's revenue has decreased by 4.7% in the latest reporting period.
- Molina Healthcare's Decline: Molina Healthcare has experienced a significant revenue drop of 27%.
- Humana's Revenue Change: Humana's revenue has seen a slight decline of 1%.
- Overall Industry Trends: The healthcare sector is facing varied financial challenges, with different companies reporting differing levels of revenue change.
See More
US Health Insurer Stocks Decline as Molina Healthcare Projects Annual Profit Below Expectations
Health Insurers' Profit Decline: U.S. health insurers are experiencing a significant drop in profits, falling below annual profit estimates.
Impact of Molina Healthcare: The decline in profits is particularly influenced by Molina Healthcare's performance and forecasts in the health care sector.
See More
Movers in the Market: Amazon, Novo Nordisk, Molina, Roblox, Hub Group, and Others
- Stock Market Movement: Stock futures increased on Friday despite concerns regarding artificial intelligence spending.
- Big Tech Earnings Impact: Recent earnings reports from major technology companies did not alleviate fears related to AI investments.
See More
